Millions lose access to free NHS earwax removal
Patients unable to afford private treatment are turning to “dangerous self-removal methods”, the RNID says.
Similar Posts
Canadian health care leaves patients frozen in line
“This year, Canadian patients faced an average wait of 27.7 weeks for medically necessary treatment,” … [+] Write pipes. getty More than a quarter of Americans receive tax-funded health coverage through Medicaid or the Children’s Health Insurance Program, according to the latest federal estimates. But that “free” coverage has a significant cost. Medicaid beneficiaries must…
Child obesity in pandemic could have lifelong effects, study says
Researchers say children who gained weight in the pandemic could develop diseases later in life.
Cancer is now leading cause of death among HIV-positive people, report says: ‘Of great concern’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Walgreens and 3 other health-care stocks are going into our Bullpen watch list
We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful of company CEOs Jim interviewed at this week’s JPMorgan…
Royal Blackburn Hospital: 'My dad, 80, spent 36 hours on corridor trolley'
Gail Myerscough says she is “horrified” patients are put on trolleys in corridors at Royal Blackburn.
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…